1. Abrams, P, Cardozo, L, Fall, M, et al. The standardisation of terminology in lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Urology 2003; 61(1): 37–49.
Google Scholar | Crossref | Medline | ISI2. The Urology Foundation . Bladder-related statistics, https://www.theurologyfoundation.org/professionals/healthcare-resources-and-reports/urology-resources/facts-and-figures/bladder-related-statistics
Google Scholar3. Bschleipfer, T, Doggweiler, R, Schultz-Lampel, D, et al. [Diagnosis and treatment of interstitial cystitis (IC/PBS): S2k guideline of the German Society of Urology]. Urologe A 2019; 58(11): 1313–1323.
Google Scholar | Crossref | Medline4. Nickel, JC, Cornish, J. Ultrastructural study of an antibody-stabilized bladder surface: A new perspective on the elusive glycosaminoglycan layer. World J Urol 1994; 12(1): 11–14.
Google Scholar | Crossref | Medline5. Cox, A, Golda, N, Nadeau, G, et al. CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. Can Urol Assoc J 2016; 10(5–6): E136–E155.
Google Scholar | Crossref | Medline6. Engeler, D, Baranowski, AP, Berghmans, B, et al. EAU guidelines on chronic pelvic pain, 2020, https://uroweb.org/guideline/chronic-pelvic-pain/
Google Scholar7. Hanno, PM, Erickson, D, Moldwin, R, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol 2015; 193(5): 1545–1553.
Google Scholar | Crossref | Medline | ISI8. Dimitrakov, J, Kroenke, K, Steers, WD, et al. Pharmacologic management of painful bladder syndrome/interstitial cystitis: A systematic review. Arch Intern Med 2007; 167(18): 1922–1929.
Google Scholar | Crossref | Medline9. Nickel, JC, Barkin, J, Forrest, J, et al. Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urology 2005; 65(4): 654–658.
Google Scholar | Crossref | Medline10. NICE . Single technology appraisal pentosan polysulfate sodium for treating bladder pain syndrome, 2018, https://www.nice.org.uk/guidance/ta610/documents/final-scope
Google Scholar11. Agency MaHpR . Elmiron (pentosan polysulfate sodium): Rare risk of pigmentary maculopathy, 2019, https://www.gov.uk/drug-safety-update/elmiron-pentosan-polysulfate-sodium-rare-risk-of-pigmentary-maculopathy
Google Scholar12. Pearce, WA, Chen, R, Jain, N. Pigmentary maculopathy associated with chronic exposure to pentosan polysulfate sodium. Ophthalmology 2018; 125(11): 1793–1802.
Google Scholar | Crossref | Medline13. Paredes Mogica, JA, De, EJB. Pentosan polysulfate maculopathy: What urologists should know in 2020. Urology 2021; 147: 109–118.
Google Scholar | Crossref | Medline14. Ludwig, CA, Vail, D, Callaway, NF, et al. Pentosan polysulfate sodium exposure and drug-induced maculopathy in commercially insured patients in the United States. Ophthalmology 2020; 127(4): 535–543.
Google Scholar | Crossref | Medline15. Jain, N, Li, AL, Yu, Y, et al. Association of macular disease with long-term use of pentosan polysulfate sodium: Findings from a US cohort. Br J Ophthalmol 2020; 104(8): 1093–1097.
Google Scholar | Crossref | Medline16. Doiron, RC, Bona, M, Nickel, JC. Possible drug-induced, vision-threatening maculopathy secondary to chronic pentosan polysulfate sodium (Elmiron((R))) exposure. Can Urol Assoc J 2020; 14(2): 10–11.
Google Scholar | Crossref | Medline17. Yeh, HL, Jhang, JF, Kuo, YC, et al. Long-term outcome and symptom improvement in patients with interstitial cystitis/bladder pain syndrome with or without regular follow-up and treatment. Neurourol Urodyn 2019; 38(7): 1985–1993.
Google Scholar | Crossref | Medline18. Douglas-Moore, JL, Goddard, J. Current best practice in the management of cystitis and pelvic pain. Ther Adv Urol 2018; 10(1): 17–22.
Google Scholar | SAGE Journals | ISI19. van Ophoven, A, Pokupic, S, Heinecke, A, et al. A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004; 172(2): 533–536.
Google Scholar | Crossref | Medline | ISI20. Foster, HE, Hanno, PM, Nickel, JC, et al. Effect of amitriptyline on symptoms in treatment naive patients with interstitial cystitis/painful bladder syndrome. J Urol 2010; 183(5): 1853–1858.
Google Scholar | Crossref | Medline | ISI21. Sant, GR, Propert, KJ, Hanno, PM, et al. A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 2003; 170(3): 810–815.
Google Scholar | Crossref | Medline22. NICE . BBNF – HYDROXYZINE HYDROCHLORIDE, 2020, https://bnf.nice.org.uk/drug/hydroxyzine-hydrochloride.html
Google Scholar23. Evans, RJ. Treatment approaches for interstitial cystitis: Multimodality therapy. Rev Urol 2002; 4(Suppl. 1): S16–S20.
Google Scholar | Medline24. Neuhaus, J, Schulte-Baukloh, H, Stolzenburg, JU, et al. Individual receptor profiling as a novel tool to support diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol 2012; 30(5): 693–700.
Google Scholar | Crossref | Medline | ISI25. Thilagarajah, R, Witherow, RO, Walker, MM. Oral cimetidine gives effective symptom relief in painful bladder disease: A prospective, randomized, double-blind placebo-controlled trial. BJU Int 2001; 87(3): 207–212.
Google Scholar | Crossref | Medline26. Tincello, DG, Walker, AC. Interstitial cystitis in the UK: Results of a questionnaire survey of members of the Interstitial Cystitis Support Group. Eur J Obstet Gynecol Reprod Biol 2005; 118(1): 91–95.
Google Scholar | Crossref | Medline